Key facts
- This page summarizes Global Michael J. Rider's Form 4 filing for RESMED INC (RMD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jun 2026, 15:45.
Global Michael J. Rider - 01 Jun 2026 Form 4 Insider Report for RESMED INC (RMD)
- Reporting relationship
- Global General Counsel
- Issuer ticker
- RMD
- Reported as of
- 01 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Jun 2026, 15:45:27 UTC
- Prior SEC filing
- 06 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael J. Rider, Global General Counsel and Secretary
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Global Michael J. Rider filed Form 4 for RESMED INC (RMD) on 03 Jun 2026.
Change
- Previous filing in this sequence was filed on 06 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001982205
Primary reporting owner
Rider Michael J
- Relationship
- Global General Counsel
- Address
- 9001 SPECTRUM CENTER BLVD, SAN DIEGO
- Signature
- /s/ Michael J. Rider, Global General Counsel and Secretary
- Signature date
- 03 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RMD
transaction
ResMed Common Stock
Tax liability
- Transaction value
- Shares
- -269
- Change %
- -2.8%
- Price
- $190.57*
- Shares after
- 9,488
- Date
- 01 Jun 2026
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 06/01/2023.
Footnote F2
Includes 66.0288 shares of Resmed stock purchased on April 30, 2026 through the Resmed Employee Stock Purchase Plan.